YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Humira


AddThis Social Bookmark Button

Injured by Humira?

On May 17, 2006 a new study discovered that patients taking Humira face triple the risk of developing several kinds of cancer and double the risk of getting severe infections. Humira (generic: Adalimumab) is manufactured by Abbott Laboratories and is prescribed to combat Rheumatoid arthritis. Humira was granted FDA approval on December 31, 2002.

Humira is in the same class of drugs as Enbrel and Remicade. These drugs are called anti-TNF drugs or TNF blocker drugs. TNF is a small protein called a cytokine, which has a major role in the regulation of the immune system. Anti-TNF drugs confine TNF and obstruct the reaction, which causes the abnormal joint inflammation.

In rheumatoid arthritis, TNF levels are very high, resulting in:
  • Inflammation
  • Swelling
  • Pain
  • Joint damage
Mayo Clinic Study
The findings of this new study can be found in the May 17, 2006 issue of the Journal of the American Medical Association. The Mayo Clinic study found an apparent link to other cancers, including skin, gastrointestinal, breast and lung tumors. Eric Matteson, a professor at the Mayo Clinic in Rochester, Minn., and an author of the study, stated that physicians might well expect to see one additional case of cancer develop within 6 to 12 months of treatment for every 154 patients who take the drugs. Doctors could expect to see one serious infection, such as pneumonia, within 3 to 12 months for every 59 patients treated. Less than 1% of patients in the study developed cancer. The Mayo Clinic study found an apparent link to other cancers, including skin, gastrointestinal, breast and lung tumors. Anti-TNF antibody drugs are one of the fastest-growing prescription classes in the nation.
 
Legal Help for Humira Users
If you or a loved one took Humira and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
HumiraRSS Feed

Humira, Cimzia, Enbrel and Remicade to Bear Stronger Infection Warnings

Sep 4, 2008 | Parker Waichman Alonso LLP
Federal regulators have ordered the makers of Humira, Cimzia, Enbrel, and Remicade to strengthen the existing warnings about opportunistic fungal infections linked to the drugs.  At least 45 people are known to have died from such infections.  The Food & Drug Administration (FDA) ordered the new labeling under authority it was granted with the passage of the Food and Drug Administration Amendments Act of 2007.Humira, Cimzia, Enbrel and Remicade are known as tumor necrosis factor...

Humira, Enbrel, Remicade Being Investigated for Cancer Link

Jun 4, 2008 | Parker Waichman Alonso LLP
Humira and other drugs used to treat autoimmune disorders are being investigated by federal regulators amid concern that they might be linked to cancer in children and young people. The drugs are known as tumor necrosis factor (TNF) blockers, and are used to treat various forms of arthritis including juvenile idiopathic arthritis and Crohn's disease.In addition to Humira, which is made by Abbott Laboratories, four other TNF blockers are currently on the market in the US.  They are Enbrel,...

Cancer Risks Detailed for Arthritis Drugs

May 17, 2006 | AP
Rheumatoid arthritis patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections, a study led by the Mayo Clinic found. The analysis builds on previous reports about the risks associated with Abbott Laboratories' Humira and Centocor's Remicade. But the earlier research focused mostly on one kind of cancer, lymphoma and infections such as tuberculosis and pneumonia. The new study found an apparent link to other...

Study: Rheumatoid-arthritis drugs may raise cancer, infection risk

May 17, 2006 | South Florida Sun-Sentinel
Some drugs used to treat rheumatoid arthritis, a devastating disease that can deform bone and cause extreme pain, may increase the risk for serious infections and also some cancers in rare cases, according to an analysis of nine studies involving the drugs. But doctors familiar with the research say the benefits of the drugs, Humira and Remicade, outweigh the risks for most people with rheumatoid arthritis. The best course of action, they say, is for doctors to monitor their patients closely...

More Humira News

Humira
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News